Indian Hotels Q4 Results: Profit Rises 29%
The Indian Hotels Co.'s consolidated net profit rose 29.3% in the fourth quarter of financial year 2024, beating analysts' estimates.
The hospitality firm's profit increased to Rs 438 crore in the quarter-ended March, according to an exchange filing on Wednesday. Analysts tracked by Bloomberg had pegged the profit at Rs 427.6 crore.
IHCLÂ Q4 FY24 Earnings Highlights (Consolidated, YoY)
Revenue up 17.2% to Rs 1,905 crore (Bloomberg estimate: Rs 1,913.8 crore).
Ebitda up 23.2% to Rs 659.2 crore (Estimate: Rs 679.5 crore).
Margin at 34.6% vs 32.9% (Estimate: 35.50%).
Net profit up 29.3% at Rs 438 crore (Estimate: Rs 427.6 crore).
Board recommended a dividend of Rs 1.75 per share.
Other Key Operational Highlights (Q4 FY24)
Occupancy up 440 bps at 79.1%.
Average room rate up 4% at Rs 17,546.
Revenue per available room up 10% at Rs 13,885.
In Q4, IHCL opened six hotels, with three hotels under SeleQtions in Jaisalmer, Tirupati and Munnar; two Ginger hotels in Durgapur and Ahmedabad; and a Vivanta in Bharatpur, Nepal. Meanwhile, in FY24, the business signed 53 hotels and opened 34 hotels.
Puneet Chhatwal, managing director and CEO, said, "Looking ahead at FY25, IHCL will continue to deliver double-digit revenue growth with new businesses at 30%, and opening of 25 hotels."
The business will also introduce the re-imagined Gateway, a full-service hotel offering in the upscale segment in emerging micro markets in metros and Tier II and Tier III cities. The brand rollout, starting with 15 hotels, will commence with launches in Bekal and Nashik this quarter, followed by destinations like Bengaluru, Thane and Jaipur. The brand will scale to a 100 hotels portfolio by 2030.
For FY24, he added, "IHCL achieves its key goals under Ahvaan 2025 well ahead of time, with a full-year consolidated Ebitda margin of 33.7%, a portfolio of 300 plus hotels and a cash position of Rs 2,206 crore."
Shares of IHCL closed 0.7% higher at Rs 608.25 apiece on the BSE, as compared with a 0.16% advance in the benchmark Sensex.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
